Cargando…

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) has become a progressive metabolic disease that is emerging as a global epidemic. Considering that the complex pathogenesis has not been fully elucidated, barely specific pharmacological therapy is recommended in current guidelines. Gentiana scabra (GS) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yiyuan, Fang, Dan, Huang, Chaoyuan, Zhao, Lina, Gan, Liming, Chen, Youlan, Liu, Fengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803634/
https://www.ncbi.nlm.nih.gov/pubmed/35115947
http://dx.doi.org/10.3389/fphar.2021.816032
_version_ 1784642909036871680
author Zheng, Yiyuan
Fang, Dan
Huang, Chaoyuan
Zhao, Lina
Gan, Liming
Chen, Youlan
Liu, Fengbin
author_facet Zheng, Yiyuan
Fang, Dan
Huang, Chaoyuan
Zhao, Lina
Gan, Liming
Chen, Youlan
Liu, Fengbin
author_sort Zheng, Yiyuan
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) has become a progressive metabolic disease that is emerging as a global epidemic. Considering that the complex pathogenesis has not been fully elucidated, barely specific pharmacological therapy is recommended in current guidelines. Gentiana scabra (GS) is a commonly used herb in Tibetan medicine, which has received much attention in recent years due to its diverse pharmacological properties, including anti-inflammation, anti-oxidation, and anti-fibrosis. However, the therapeutic mechanisms are still unclear. Our investigation demonstrated a regulatory effect of GS on pro-inflammatory macrophages, which was extensively investigated in NAFLD that revealed intimate participation in the disease evolution, and the non-canonical IKK family member TANK-binding kinase 1 (TBK1) was involved in this process. Plasmid vectors for shTBK1 and amlexanox (AML), an inhibitor of TBK1, were used in this study to verify the mechanisms of TBK1 both in vitro and in vivo, while a co-culture system for hepatocytes and BMDMs was constructed to confirm the critical role of macrophages for inflammatory cascade. The results revealed that metabolic burden up-regulated the phosphorylation of TBK1, resulting in activation of NF-κB signaling pathway, and consequently caused an elevated expression of MCP1 to induce the macrophage recruitment and accelerate the inflammatory cascade. In contrast, GS could inhibit the TBK1 phosphorylation and the MCP1 expression to restrain the recruitment of pro-inflammatory macrophages, so as to provide curative effects on metabolic dysfunction and inflammation. Considering that GS is non-toxic and can be used as a kind of tea for long-term drinking, we propose it may be an effective option for the prevention and treatment of NAFLD, which deserves further exploration and application, and may provide new insights to improve the current standardized intervention strategy.
format Online
Article
Text
id pubmed-8803634
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88036342022-02-02 Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease Zheng, Yiyuan Fang, Dan Huang, Chaoyuan Zhao, Lina Gan, Liming Chen, Youlan Liu, Fengbin Front Pharmacol Pharmacology Non-alcoholic fatty liver disease (NAFLD) has become a progressive metabolic disease that is emerging as a global epidemic. Considering that the complex pathogenesis has not been fully elucidated, barely specific pharmacological therapy is recommended in current guidelines. Gentiana scabra (GS) is a commonly used herb in Tibetan medicine, which has received much attention in recent years due to its diverse pharmacological properties, including anti-inflammation, anti-oxidation, and anti-fibrosis. However, the therapeutic mechanisms are still unclear. Our investigation demonstrated a regulatory effect of GS on pro-inflammatory macrophages, which was extensively investigated in NAFLD that revealed intimate participation in the disease evolution, and the non-canonical IKK family member TANK-binding kinase 1 (TBK1) was involved in this process. Plasmid vectors for shTBK1 and amlexanox (AML), an inhibitor of TBK1, were used in this study to verify the mechanisms of TBK1 both in vitro and in vivo, while a co-culture system for hepatocytes and BMDMs was constructed to confirm the critical role of macrophages for inflammatory cascade. The results revealed that metabolic burden up-regulated the phosphorylation of TBK1, resulting in activation of NF-κB signaling pathway, and consequently caused an elevated expression of MCP1 to induce the macrophage recruitment and accelerate the inflammatory cascade. In contrast, GS could inhibit the TBK1 phosphorylation and the MCP1 expression to restrain the recruitment of pro-inflammatory macrophages, so as to provide curative effects on metabolic dysfunction and inflammation. Considering that GS is non-toxic and can be used as a kind of tea for long-term drinking, we propose it may be an effective option for the prevention and treatment of NAFLD, which deserves further exploration and application, and may provide new insights to improve the current standardized intervention strategy. Frontiers Media S.A. 2022-01-18 /pmc/articles/PMC8803634/ /pubmed/35115947 http://dx.doi.org/10.3389/fphar.2021.816032 Text en Copyright © 2022 Zheng, Fang, Huang, Zhao, Gan, Chen and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zheng, Yiyuan
Fang, Dan
Huang, Chaoyuan
Zhao, Lina
Gan, Liming
Chen, Youlan
Liu, Fengbin
Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title_full Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title_fullStr Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title_short Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
title_sort gentiana scabra restrains hepatic pro-inflammatory macrophages to ameliorate non-alcoholic fatty liver disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803634/
https://www.ncbi.nlm.nih.gov/pubmed/35115947
http://dx.doi.org/10.3389/fphar.2021.816032
work_keys_str_mv AT zhengyiyuan gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT fangdan gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT huangchaoyuan gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT zhaolina gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT ganliming gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT chenyoulan gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease
AT liufengbin gentianascabrarestrainshepaticproinflammatorymacrophagestoamelioratenonalcoholicfattyliverdisease